[Genesis of glycoside poisoning in myocardial infarct and its rational pharmacoprevention].
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D002415:Cats; D000242:Cyclic AMP / Q000378:metabolism; D004285:Dogs; D004342:Drug Hypersensitivity; D006321:Heart / Q000503:physiopathology; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D011188:Potassium / Q000627:therapeutic use; D013564:Sympathetic Nervous System / Q000503:physiopathology; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002301:Cardiac Glycosides; D000242:Cyclic AMP; D011188:Potassium
Genez glikozidnoĭ intoksikatsii pri infarkte miokarda i ee ratsional'naia farmakoprofilaktika.